These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 34008471)
1. Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand. Rochanathimoke O; Riewpaiboon A; Praditsitthikorn N; Tharmaphornpilas P; Jiamsiri S; Thavorncharoensap M; Postma MJ Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):811-819. PubMed ID: 34008471 [TBL] [Abstract][Full Text] [Related]
2. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand. Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study. Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252 [TBL] [Abstract][Full Text] [Related]
4. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan. Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model. Patel HD; Roberts ET; Constenla DO Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of rotavirus vaccination among Libyan children using a simple economic model. Alkoshi S; Orhun NM; Dahlui M Libyan J Med; 2014; 9(1):26236. PubMed ID: 25499622 [TBL] [Abstract][Full Text] [Related]
7. Estimated impact and cost-effectiveness of rotavirus vaccination in Senegal: A country-led analysis. Diop A; Atherly D; Faye A; Lamine Sall F; Clark AD; Nadiel L; Yade B; Ndiaye M; Fafa Cissé M; Ba M Vaccine; 2015 May; 33 Suppl 1():A119-25. PubMed ID: 25919151 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160 [TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea. Kang HY; Kim KH; Kim JH; Kim HM; Kim J; Kim MS; El Khoury AC; Kim DS Asia Pac J Public Health; 2013 Mar; 25(2):145-58. PubMed ID: 22234827 [TBL] [Abstract][Full Text] [Related]
10. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria. Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of rotavirus vaccination in Argentina. Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152 [TBL] [Abstract][Full Text] [Related]
13. Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia. Lusvan ME; Debellut F; Clark A; Demberelsuren S; Otgonbayar D; Batjargal T; Purevsuren S; Groman D; Tate J; Pecenka C Vaccine; 2019 Feb; 37(6):798-807. PubMed ID: 30639458 [TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of a pentavalent rotavirus vaccine in Oman. Al Awaidy ST; Gebremeskel BG; Al Obeidani I; Al Baqlani S; Haddadin W; O'Brien MA BMC Infect Dis; 2014 Jun; 14():334. PubMed ID: 24941946 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of rotavirus vaccination in Albania. Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162 [TBL] [Abstract][Full Text] [Related]
16. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan. Anwari P; Debellut F; Pecenka C; Parwiz SM; Clark A; Groman D; Safi N Vaccine; 2018 Dec; 36(51):7769-7774. PubMed ID: 29107346 [TBL] [Abstract][Full Text] [Related]
17. Economic burden of rotavirus diarrhea in Thailand: Report from a pilot study on rotavirus vaccination. Rochanathimoke O; Riewpaiboon A; Tharmaphornpilas P; Jiamsiri S; Thavorncharoensap M; Postma MJ Vaccine; 2019 Jan; 37(4):587-594. PubMed ID: 30579755 [TBL] [Abstract][Full Text] [Related]
18. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia. De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan. Itzler RF; Chen PY; Lac C; El Khoury AC; Cook JR J Med Econ; 2011; 14(6):748-58. PubMed ID: 21919673 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda. Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ; Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]